Figure 1 | British Journal of Cancer

Figure 1

From: Multimarker RT–PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients

Figure 1

Gel electrophoresis of PCR products of the three molecular markers. Five representative sentinel lymph nodes (SLN) were chosen and amplified again for demonstration of the three markers used in the study: cytokeratin-19 (CK-19), mammaglobin-2 (MGB-2) and NY-BR-1. All five SLNs showed amplification of all three markers (lanes #1–5). Representative negative controls including one lymph node obtained from a patient with disease other than breast cancer (LN, lane #6) and peripheral blood lymphocytes obtained form healthy volunteers (PBL, lanes #7–9). Three primary tumours were used as positive controls (TU, lanes #10–12).

Back to article page